Yahav Achim Ve Achayot Provident Funds Management CO Ltd. Chemomab Therapeutics Ltd. Transaction History

Yahav Achim Ve Achayot Provident Funds Management CO Ltd.

$35.2 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 12, 2022	SELL	$3.53 - $7.2 $10,932 - $22,298	-3,097 Closed	0 $0
Q3 2021 Nov 17, 2021	BUY	$11.08 - $19.17 $34,314 - $59,369	3,097 New	3,097 $34,000

Others Institutions Holding CMMB

# of Institutions

Shares Held

4.56M

Call Options Held

Put Options Held

Orbimed Advisors LLC San Diego, CA

1.74M
Shares

$4.02 Million
0.06% of portfolio
Sphera Funds Management Ltd. Tel Aviv, L3

1.21M
Shares

$2.81 Million
0.35% of portfolio
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3

810K
Shares

$1.87 Million
0.21% of portfolio
Morgan Stanley New York, NY

402K
Shares

$929,248
0.0% of portfolio
Ikarian Capital, LLC Dallas, TX

213K
Shares

$492,935
0.06% of portfolio

View Full List

About Chemomab Therapeutics Ltd.

Ticker CMMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,431,700
Market Cap $26.4M
Description
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...

More about CMMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Yahav Achim Ve Achayot Provident Funds Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Yahav Achim Ve Achayot Provident Funds Management CO Ltd. with notifications on news.

Account